• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆和尿液中地高辛的灵敏放射免疫测定法。

Sensitive radioimmunoassay for digoxin in plasma and urine.

作者信息

Wagner J G, Hallmark M R, Sakmar E, Ayres J W

出版信息

Steroids. 1977 Jun;29(6):787-807. doi: 10.1016/0039-128x(77)90122-2.

DOI:10.1016/0039-128x(77)90122-2
PMID:910251
Abstract

A reproducible and sensitive radioimmunoassay for digoxin in either serum, plasma or urine is described. Using 0.5 ml of serum or plasma, the assay sensitivity is 0.05 ng of digoxin/ml. The antiserum and tracer solutions employed are available in a kit sold in the United States. All other reagents were prepared in the laboratory. The assay allows measurement of digoxin in plasma or serum for 96 hours after single 0.5 mg doses of digoxin; this is necessary in human bioavailability studies to accurately estimate the total area under the digoxin concentration, time curve from zero to infinite time. In contrast, with the kit assay, employing 0.2 ml of plasma or serum, it has been reported that the 12 hr serum digoxin levels, after single 0.5 mg doses, are, in most subjects, below the sensitivity limit (about 0.5 ng/ml) of the assay.

摘要

本文描述了一种用于检测血清、血浆或尿液中地高辛的可重复且灵敏的放射免疫分析方法。使用0.5毫升血清或血浆时,该分析方法的灵敏度为每毫升0.05纳克地高辛。所使用的抗血清和示踪剂溶液可在美国销售的试剂盒中获得。所有其他试剂均在实验室制备。该分析方法能够在单次给予0.5毫克地高辛剂量后96小时内测定血浆或血清中的地高辛;这在人体生物利用度研究中对于准确估计地高辛浓度-时间曲线从零到无限时间的总面积是必要的。相比之下,据报道,使用该试剂盒分析方法,采用0.2毫升血浆或血清,在单次给予0.5毫克剂量后,大多数受试者在12小时时的血清地高辛水平低于该分析方法的灵敏度极限(约0.5纳克/毫升)。

相似文献

1
Sensitive radioimmunoassay for digoxin in plasma and urine.血浆和尿液中地高辛的灵敏放射免疫测定法。
Steroids. 1977 Jun;29(6):787-807. doi: 10.1016/0039-128x(77)90122-2.
2
Digoxin-like immunoreactivity in normal human plasma and urine, as detected by a solid-phase radioimmunoassay.
Clin Chem. 1984 Mar;30(3):450-1.
3
Specific and sensitive assays for digoxin in plasma, urine and heart tissue.针对血浆、尿液和心脏组织中地高辛的特异性和灵敏性检测方法。
Res Commun Chem Pathol Pharmacol. 1981 Feb;31(2):285-98.
4
Development of radioimmunoassay for measurement of serum digoxin in digitalized patients using novel anti-digoxin antiserum.使用新型抗地高辛抗血清开发用于测量洋地黄化患者血清地高辛的放射免疫测定法。
Biol Pharm Bull. 2002 Apr;25(4):422-5. doi: 10.1248/bpb.25.422.
5
A routine method for the determination of digoxin in urine by radioimmunoassay.
Clin Chim Acta. 1982 Mar 26;120(1):13-9. doi: 10.1016/0009-8981(82)90072-9.
6
Factors of importance for valid digitalis assays particularly for the determination of digoxin in plasma and urine.
Acta Pharmacol Toxicol (Copenh). 1986;59 Suppl 4:1-62.
7
[Evaluation of stat assay of serum digoxin concentration by radioimmunoassay and its application for digoxin regimen based in pharmacokinetics (author's transl)].血清地高辛浓度放射免疫分析法的测定评估及其在基于药代动力学的地高辛治疗方案中的应用(作者译)
Radioisotopes. 1980 Sep;29(9):432-7. doi: 10.3769/radioisotopes.29.9_432.
8
Some factors affecting a commercial kit for radioimmunoassay of digoxin using tritiated digoxin.
J Clin Chem Clin Biochem. 1977 May;15(5):261-6. doi: 10.1515/cclm.1977.15.1-12.261.
9
A solid phase radioimmunoassay for digoxin and its acylated derivatives.
Naunyn Schmiedebergs Arch Pharmacol. 1975;287(3):309-19. doi: 10.1007/BF00501476.
10
Radioimmunoassay of salivary digoxin by simple adaptation of a kit method for serum digoxin: saliva/serum ratio and correlation.通过简单改编血清地高辛试剂盒法进行唾液地高辛放射免疫分析:唾液/血清比值及相关性
Ther Drug Monit. 1987;9(1):91-6. doi: 10.1097/00007691-198703000-00016.

引用本文的文献

1
Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.
J Pharmacokinet Biopharm. 1979 Apr;7(2):147-58. doi: 10.1007/BF01059735.
2
Evidence of nonlinearity in digoxin pharmacokinetics.
J Pharmacokinet Biopharm. 1981 Apr;9(2):147-66. doi: 10.1007/BF01068079.
3
Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.
J Pharmacokinet Biopharm. 1977 Oct;5(5):533-57. doi: 10.1007/BF01061733.